Warning

2006-23
April 28, 2006
For immediate release

Health Canada warns consumers not to use Miracle Bion product

OTTAWA - Health Canada is warning consumers not to use the health product Miracle Bion as it could be contaminated with bacteria such as E. coli.

There are two varieties of Miracle Bion - Alpha and Omega. Neither are approved by Health Canada.

The Omega version can be used for intravenous use and this could result in serious infection and is therefore a serious and potentially life-threatening health risk. The Omega version is also advertised for external use on skin and for oral use in children. The Alpha version is manufactured as a black liquid and in capsule form and is for oral use only. Both versions present a health risk and should not be used.

Common symptoms of E. coli include fever, vomiting and diarrhea. Symptoms can also be more serious. Consumers who may have used Miracle Bion and are concerned about their health should contact a health care professional.

Miracle Bion, distributed in Canada by Clinique naturopathique de la Cité, contains humic and fulvic acids, which come from humus. Humus is made up of decomposed plant and animal residues, is found in soil, and could be contaminated with many types of bacteria such as E. coli.

Miracle Bion is being promoted as an immune system booster and as a treatment for serious diseases, such as cancer, asthma, dementia, influenza, tuberculosis, epilepsy and arthritis.

These diseases should not be self-diagnosed or self-medicated and should only be treated under the supervision of a health care provider. It is important to discuss the use of any non-prescription products - including vitamins, minerals and natural health products - with your health care provider.

The distributor of Miracle Bion has refused to comply with Health Canada requests to recall and stop selling these products.

Consumers should not discard this product without checking first with their Municipal Government regarding safe disposal.

To report finding this product on the Canadian market, please contact the Health Products and Food Branch Inspectorate at: 1-800-267-9675.

To report a suspected adverse reaction, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada at:
Telephone: 866-234-2345, Facsimile: 866-678-6789

CADRMP
Marketed Health Products Directorate
Health Protection Building, Tunney's Pasture, AL 0701C
Ottawa, Ontario K1A 0K9
Email: cadrmp@hc-sc.gc.ca

Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

-30-

---

Media Inquiries:
Health Canada
(613) 957-2983

Public Inquiries:
(613) 957-2991
1-866 225-0709